Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022821
Filing Date
2020-05-07
Accepted
2020-05-07 16:03:01
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20200331.htm 10-Q 1607621
2 EX-3.1 ttph-ex31_220.htm EX-3.1 1340207
3 EX-31.1 ttph-ex311_10.htm EX-31.1 17275
4 EX-31.2 ttph-ex312_8.htm EX-31.2 17530
5 EX-32.1 ttph-ex321_7.htm EX-32.1 6190
6 EX-32.2 ttph-ex322_9.htm EX-32.2 6481
  Complete submission text file 0001564590-20-022821.txt   6571977

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ttph-20200331.xml EX-101.INS 874652
8 XBRL TAXONOMY EXTENSION SCHEMA ttph-20200331.xsd EX-101.SCH 51356
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20200331_cal.xml EX-101.CAL 37698
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20200331_def.xml EX-101.DEF 140728
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20200331_lab.xml EX-101.LAB 383070
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20200331_pre.xml EX-101.PRE 270318
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 20856217
SIC: 2834 Pharmaceutical Preparations